Health, Medicine and Natural Healing 11

179,008 topics in this forum

1. Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis

   By Guest guest, January 22, 2011
   • 0 replies
   • 37 views
   • 
   • Guest
   • January 22, 2011

2. Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib

   By Guest guest, January 22, 2011
   • 0 replies
   • 30 views
   • 
   • Guest
   • January 22, 2011

3. Spanish scientists sequence the genome for chronic lymphocytic leukemia

   By Guest guest, June 13, 2011
   • 0 replies
   • 18 views
   • 
   • Guest
   • June 13, 2011

4. Health Risks of Nuclear-Power-Plant Accidents

   By Guest guest, June 16, 2011
   • 0 replies
   • 22 views
   • 
   • Guest
   • June 16, 2011

5. Insights into the Biology of CLL

   By Guest guest, January 19, 2011
   • 0 replies
   • 33 views
   • 
   • Guest
   • January 19, 2011

6. Avila Therapeutics Presents Data Demonstrating The Relevance Of Its Btk Inhibitor, AVL-292, In B Cell Malignancies Such As CLL

   By Guest guest, June 16, 2011
   • 0 replies
   • 44 views
   • 
   • Guest
   • June 16, 2011

7. Hospitals Performed Needless Double CT Scans, Records Show

   By Guest guest, June 18, 2011
   • 1 reply
   • 29 views
   • 
   • Guest
   • June 19, 2011

8. Autologous stem cell transplantation as a first-line treatment strategy for CLL

   By Guest guest, June 20, 2011
   • 0 replies
   • 41 views
   • 
   • Guest
   • June 20, 2011

9. What is Epigenetic Priming?

   By Guest guest, June 20, 2011
   • 0 replies
   • 53 views
   • 
   • Guest
   • June 20, 2011

10. Practical considerations and questions in the treatment of chronic lymphocytic leukemia

    By Guest guest, June 20, 2011
    • 0 replies
    • 35 views
    • 
    • Guest
    • June 20, 2011

11. What is CAL 101?

    By Guest guest, January 18, 2011
    • 0 replies
    • 35 views
    • 
    • Guest
    • January 18, 2011

12. Study: CT adds little value for many CLL patients

    By Guest guest, January 17, 2011
    • 0 replies
    • 36 views
    • 
    • Guest
    • January 17, 2011

13. Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma

    By Guest guest, January 14, 2011
    • 0 replies
    • 56 views
    • 
    • Guest
    • January 14, 2011

14. Second evaluations of biopsy sample?

    By Guest guest, January 9, 2011
    • 0 replies
    • 48 views
    • 
    • Guest
    • January 9, 2011

15. Re: OT: Antibodies help repair nerve cells; except in the spine and brain.

    By Guest guest, January 8, 2011
    • 0 replies
    • 50 views
    • 
    • Guest
    • January 8, 2011

16. FDA Approval: Rituximab in Combination with Fludarabine and Cyclophosphamide for the Treatment of Patients with Chronic Lymphocytic Leukemia

    By Guest guest, January 8, 2011
    • 0 replies
    • 57 views
    • 
    • Guest
    • January 8, 2011

17. Re: OT: fraudulent study exposed - responses

    By Guest guest, January 10, 2011
    • 1 reply
    • 48 views
    • 
    • Guest
    • January 10, 2011

18. Is clinical testing still needed in era of targeted drugs?

    By Guest guest, January 14, 2011
    • 0 replies
    • 29 views
    • 
    • Guest
    • January 14, 2011

19. The lymph node microenvironment promotes B-cell receptor signaling, NF-(kappa) B activation, and tumor proliferation in chronic lymphocytic leukemia

    By Guest guest, January 14, 2011
    • 0 replies
    • 60 views
    • 
    • Guest
    • January 14, 2011

20. CLL microenvironment: macro important

    By Guest guest, January 14, 2011
    • 0 replies
    • 36 views
    • 
    • Guest
    • January 14, 2011

21. Evaluation of antigen-specific immune responses in the context of gene-modified tumor cell vaccines for CLL

    By Guest guest, January 15, 2011
    • 0 replies
    • 39 views
    • 
    • Guest
    • January 15, 2011

22. miRNA/TP53 Feedback Circuitry

    By Guest guest, January 13, 2011
    • 2 replies
    • 64 views
    • 
    • Guest
    • January 15, 2011

23. The science of trashing papers

    By Guest guest, January 17, 2011
    • 0 replies
    • 31 views
    • 
    • Guest
    • January 17, 2011

24. FCR for CLL - conflict of interest?

    By Guest guest, January 20, 2011
    • 0 replies
    • 34 views
    • 
    • Guest
    • January 20, 2011

25. Healthcare Education and webTV – a new research blog from The Patients Voice

    By Guest guest, January 24, 2011
    • 0 replies
    • 24 views
    • 
    • Guest
    • January 24, 2011